SCHEMBL10375879

SCHEMBL10375879

CC(O)N(C(=O)CCCCOc1ccc(Cl)c([N+](=O)[O-])c1C=O)C1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 4/20 0.36
PDE3A Q14432 4/20 0.36
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 3/20 0.35
KMT2A Q03164 3/20 0.34
NPSR1 Q6W5P4 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
PTGDR2 Q9Y5Y4 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 2/20 0.33
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10375063 0.99 MAPK1 (0.37) PDE3BPDE3AMAPK1SMN1; SMN2LMNA
SCHEMBL10376966 0.99 MAPK1 (0.37) PDE3BPDE3AMAPK1SMN1; SMN2LMNA
SCHEMBL10376744 0.97 PDE3B (0.38) PDE3BPDE3AMAPK1SMN1; SMN2LMNA
SCHEMBL10374639 0.89 LMNA (0.42) MAPK1SMN1; SMN2LMNAALDH1A1KMT2A
SCHEMBL7310674 0.87 SMN1; SMN2 (0.35) PDE3BPDE3ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL10375880 0.83 PDE3B (0.39) PDE3BPDE3ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL7311384 0.83 PDE3B (0.40) PDE3BPDE3AMAPK1SMN1; SMN2LMNA
SCHEMBL10754703 0.83 PDE3B (0.42) PDE3BPDE3AMAPK1SMN1; SMN2LMNA
SCHEMBL10376968 0.82 PDE3B (0.39) PDE3BPDE3ASMN1; SMN2ALDH1A1KMT2A
SCHEMBL10375064 0.82 PDE3B (0.39) PDE3BPDE3ASMN1; SMN2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0116948-B1 (2-OXO-1,2,3,5-TETRAHYDROIMIDAZO-(2,1-B)QUINAZOLINYL)-OXYALKYL-AMIDES SYNTEX (U.S.A.) INC. (US) 1990-01-03 EP disclosed
US-4663320-A ANTITUMOR AGENTS, ANTICOAGULANTS SYNTEX (U.S.A.) INC. (US) 1987-05-05 US disclosed
US-4551459-A Method of treating heart failure using (2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-b]quinazolinyl)oxyalkylamides SYNTEX (U.S.A.) INC. (US) 1985-11-05 US disclosed
US-4490371-A ANTICOAGULANTS, PHOSPHODIESTERASE INHIBITORS SYNTEX (U.S.A.) INC. (US) 1984-12-25 US disclosed
EP-0116948-A2 (2-Oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)-oxyalkyl-amides SYNTEX (U.S.A.) INC. (US) 1984-08-29 EP disclosed